Post-Traumatic Stress Disorder — Orvepitant (GW823296) in Adult Post Traumatic Stress Disorder
Citation(s)
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Fixed-Dose Study Evaluating the Efficacy and Safety of the Neurokinin-1 Receptor Antagonist Orvepitant (GW823296) in Post Traumatic Stress Disorder (PTSD)